Mid cap News

In a note to clients, BTIG reportedly said short-term crypto flows remain sensitive to macro data and shifting risk appetite.

Chief Marketing Officer Dara Brady said that to date, Ryanair has signed up over 55,000 prime members, generating over €4.4 million in subscription fees.

Barclays raised its price target on Abercrombie & Fitch to $94 from $84 and maintained an ‘Equal Weight’ rating, according to TheFly.

According to Salesforce data, the firm expects total digital sales on Thanksgiving to reach $36 billion globally and $8.6 billion in the U.S.

Dow Jones futures were up by 0.11% before the halt, and the S&P 500 futures rose 0.1%.

Dow Jones futures were up by 0.17% at the time of writing, and the S&P 500 futures rose 0.32%.

Piper Sandler projected long-term growth backed by rising use of Esperion’s LDL-lowering therapies and expanding payer coverage.

The company said it expects fiscal 2025 comparable sales of 0.5% to 1.2%, which compares with prior guidance of between 1% fall and 1% rise.

Klarna co-founder and CEO Sebastian Siemiatkowski stated that the company’s 114 million customers and $112 billion in annual GMV give it the scale to transform payments globally.

Abercrombie now expects net sales to grow in the range of 6% to 7% for fiscal year 2025, compared with the prior forecast of 5% to 7% rise.

The company said that these actions, along with additional merger and integration costs, are expected to result in future pre-tax charges of $500 million to $750 million.

Kohl’s now expects annual adjusted earnings per share in the range of $1.25 to $1.45, compared with the previous forecast of $0.50 to $0.80.

While Dow Jones futures were down by 0.17% at the time of writing, the S&P 500 futures fell 0.22%.

The $18-per-share offer was proposed by major shareholders Ray Zage and James Lu.

Strong new Phase 3 Ziihera data boosted confidence in upcoming regulatory milestones.

MFI announces $500 million PIPE to support Bitcoin-backed digital asset strategy.

While Dow Jones futures were up by 0.44% at the time of writing, the S&P 500 futures rose 0.17%.

The latest Oswego fire is the plant’s third in two months, adding to the uncertainty around Novelis’ planned restart and ongoing aluminum supply constraints.

Elastic investors were not satisfied with the AI-enabled search company’s beat-and-raise quarter.

HBO said that “A Knight of the Seven Kingdoms” has been renewed for a second season, ahead of the first season debut in January next year.

The company said it was revising its full-year 2025 net sales guidance to a decline in the low single digits, compared with the previous forecast of 1.5% to 2.7% growth.

While Dow Jones futures were up by 0.61% at the time of writing, the S&P 500 futures rose 1.19%.

According to a CNBC report, Perplexity AI has partnered with PayPal ahead of the launch.

Kraken’s new valuation marks a 33% jump from its prior fundraising round.

The company now expects fiscal 2026 earnings per share to be in the range of $4.63 to $4.66, compared with the previous forecast of $4.52 to $4.57.

The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations.

While Dow Jones futures were up by 0.13% at the time of writing, the S&P 500 futures fell 0.04%.

Nokia said it now expects to grow its annual comparable operating profit to a range of €2.7 billion to €3.2 billion by 2028.

Retail traders appear to have taken a downbeat stance on Trump’s media company amid its fundamental troubles and in general disgruntlement over geopolitics following his reelection.

According to a CNBC report, the companies in separate statements said they were letting their AGA memberships go because of the direction of online betting.

While Dow Jones futures were down by 0.33% at the time of writing, the S&P 500 futures fell 0.27%.

YTD, D-Wave has outperformed among the lot, with a gain of over 170%.

Morgan Stanley and RBC boosted their targets after Rolls-Royce reaffirmed guidance and reported strengthening engine demand.

Invivyd said proceeds will support preparation for a potential VYD2311 launch and broader pipeline development.

Galmed reported new data showing that its Aramchol–Stivarga–Metformin combination improved tumor cell killing in GI cancer models.

Alphabet’s Class A shares were up more than 4% in Monday’s midday session after Berkshire Hathaway disclosed a $4.34 billion investment in the company in the third quarter.

Lee said Ethereum’s valuation metrics, like assets locked on-chain and long-term ratios to Bitcoin, indicate it may be nearing a bottom.

The company said that under the terms of the agreement, Sealed Air stockholders will receive $42.15 in cash per share.

While Dow Jones futures were down by 0.06% at the time of writing, the S&P 500 futures rose 0.26%.

According to a Wall Street Journal report, citing people familiar with the matter, both companies have held constructive talks in recent months but have yet to agree to a deal.

FDA added a boxed warning to Elevidys after two pediatric deaths and imposed stricter monitoring rules.

Merck’s all-cash agreement grants it access to Cidara’s lead flu-prevention antibody, CD388, which has received FDA Breakthrough Therapy designation and is currently in late-stage studies enrolling more than 6,000 participants.

Retail traders focused on AI-driven biopsy findings and clearer dose-response exuded increased confidence in pemvidutide’s potential.

The CHMP issued a negative trend vote but postponed its final decision to December.

Jefferies also raised its price target on Gap to $30 from $22 and noted that there remains "meaningful upside" for the shares.

SoundHound's stock has seen significant volatility this year despite the company’s deal flow momentum.

The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.

The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 nearing Phase 3.

APLD retail traders held firm despite the recent volatility in its stock price.

The selloff comes as blarcamesine completed its oral explanation during the EMA’s Nov. 10–13 review window.